BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2724516)

  • 41. Effect of prostaglandin E1 infusion in severe chronic heart failure.
    Pacher R; Stanek B; Hülsmann M; Sinzinger H
    Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandin E1 for refractory right heart failure after coronary artery bypass grafting.
    Dewhirst WE
    J Cardiothorac Anesth; 1988 Feb; 2(1):56-9. PubMed ID: 2979133
    [No Abstract]   [Full Text] [Related]  

  • 44. Vasodilator therapy for right ventricular failure.
    Sakaguchi K; Tanaka N; Sawada M; Araki Y; Fujita K
    Jpn Circ J; 1984 Apr; 48(4):357-64. PubMed ID: 6538914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation.
    Hülsmann M; Stefenelli T; Berger R; Sturm B; Parkner A; Zuckermann A; Woloszczuk W; Pacher R
    J Heart Lung Transplant; 2000 Oct; 19(10):939-45. PubMed ID: 11044687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery.
    Abe K; Sakakibara T; Miyamoto Y; Ohnishi K
    Eur J Clin Pharmacol; 1998 Mar; 54(1):21-5. PubMed ID: 9591925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemodynamic effects of anti-arrhythmia therapy on left ventricular function].
    Scheininger M
    Internist (Berl); 1990 Mar; 31(3 Suppl [ Anniv No TIARRH):9-11. PubMed ID: 2351534
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of prostaglandin E1 to treat peri-anaesthetic pulmonary hypertension associated with mitral valve disease.
    Mikawa K; Maekawa N; Goto R; Yaku H; Nishina K; Obara H
    J Int Med Res; 1993; 21(3):161-4. PubMed ID: 8299860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E1 in pulmonary hypertension of collagen disease.
    Kawahara R; Takezawa J; Mike N; Fukui S; Nishimura M; Tachimori Y; Taenaka N; Yoshiya I
    Crit Care Med; 1987 Sep; 15(9):884-5. PubMed ID: 3621967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical use of prostaglandin E1 during intracranial surgery].
    Kito T; Otagiri T; Sasano J; Narita M; Mishima W; Kamijo Y; Hokama M; Matsuo K
    Masui; 1990 May; 39(5):600-4. PubMed ID: 2384955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group.
    Bone RC; Slotman G; Maunder R; Silverman H; Hyers TM; Kerstein MD; Ursprung JJ
    Chest; 1989 Jul; 96(1):114-9. PubMed ID: 2661155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Afterload reduction in treatment of congestive heart failure.
    Komansky HJ; Zagoren AJ
    J Am Osteopath Assoc; 1979 Jan; 78(5):326-31. PubMed ID: 759416
    [No Abstract]   [Full Text] [Related]  

  • 53. The haemodynamic effects of sublingual nitroglycerin spray in severe left ventricular failure.
    Edwards JD; Grant PT; Plunkett P; Nightingale P
    Intensive Care Med; 1989; 15(4):247-9. PubMed ID: 2501371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of prostaglandin E1 in postoperative surgical patients with circulatory deficiency.
    Appel PL; Shoemaker WC; Kram HB
    Chest; 1991 Apr; 99(4):945-50. PubMed ID: 2009800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effect of long-term PGE1-treatment in left ventricular heart failure.
    Virgolini I; Kaliman J; Fitscha P; O'Grady J; Rogatti W; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):177-80. PubMed ID: 2622971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of prostaglandin E1 on renal function after cardiac surgery involving cardiopulmonary bypass.
    Abe K; Sakakibara T; Yoshiya I
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):627-31. PubMed ID: 8415813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasodilators. A re-evaluation of their role in heart failure.
    Stevenson LW; Fonarow G
    Drugs; 1992 Jan; 43(1):15-36. PubMed ID: 1372857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic improvement following a single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure.
    Schreiber R; Maier PT; Gunnar RM; Loeb HS
    Chest; 1979 Nov; 76(5):571-5. PubMed ID: 498831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epinephrine for acute decompensated heart failure and low output state: friend or foe?
    Morici N; Sacco A; Oliva F; Ferrari S; Paino R; Milazzo F; Frigerio M; Pirola R; Klugmann S; Mafrici A
    Int J Cardiol; 2011 Jun; 149(3):384-5. PubMed ID: 21439660
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of left intraatrial infusion of prostaglandin E1 after open-heart surgery.
    Imawaki S; Maeta H; Arioka I; Ugawa T; Tsuruno Y; Yamashita Y; Hagiike M; Tanaka S
    Surg Today; 1995; 25(2):136-8. PubMed ID: 7772916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.